SCHEMBL340402

SCHEMBL340402

Cc1cc2ccccc2c(C(=O)O)c1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.63
KDM4E B2RXH2 1/20 0.63
MEN1 O00255 1/20 0.63
ALDH1A1 P00352 1/20 0.63
GLA P06280 1/20 0.63
HPGD P15428 1/20 0.63
CYP2C19 P33261 1/20 0.63
KMT2A Q03164 1/20 0.63
HSD17B10 Q99714 1/20 0.63
ME2 P23368 1/20 0.52
ME1 P48163 1/20 0.52
ME3 Q16798 1/20 0.52
LDHA P00338 7/20 0.47
LDHB P07195 5/20 0.47
CYP3A4 P08684 1/20 0.47
STAT6 P42226 1/20 0.47
HIF1A Q16665 1/20 0.47
PDE10A Q9Y233 2/20 0.46
DHODH Q02127 2/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791213 0.86 CYP1A2 (0.58) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL7181506 0.85 MEN1 (0.68) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL497405 0.84 KMT2A (0.66) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL88986 0.81 CYP1A2 (0.68) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL29779946 0.81 CYP1A2 (0.68) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL28655048 0.81 ALDH1A1 (0.61) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL3978723 0.81 CYP1A2 (0.61) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL12270374 0.81 MEN1 (0.61) CYP1A2KDM4EMEN1ALDH1A1GLA
SCHEMBL12972497 0.81 ME2 (0.62) CYP1A2KDM4EMEN1ALDH1A1GLA
Hydrochloric Acid SCHEMBL11313207 0.80 CYP1A2 (0.66) CYP1A2KDM4EMEN1ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3719617-B1 MULTIFUNCTIONAL PEN MITSUBISHI PENCIL CO (JP) 2023-08-16 EP disclosed
EP-3362518-B1 SENSOR DYES FOR REAL-TIME SENSING OF METAL IONS IN AQUEOUS ENVIRONMENTS THE UWM RES FOUNDATION INC (US) 2022-04-27 EP disclosed
US-11221686-B2 Multifunction pen MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2022-01-11 US disclosed
US-11059967-B2 Epoxy stabilization using acid-coated nitrogen containing catalysts, particles, and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-07-13 US disclosed
US-20200363881-A1 MULTIFUNCTION PEN MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2020-11-19 US disclosed
EP-3719617-A1 MULTIFUNCTIONAL PEN Mitsubishi Pencil Company, Limited (JP) 2020-10-07 EP disclosed
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE ORMCO CORPORATION 2017-08-03 US disclosed
WO-2017066672-A1 SENSOR DYES FOR REAL-TIME SENSING OF METAL IONS IN AQUEOUS ENVIRONMENTS UWM RESEARCH FOUNDATION, INC. (US) 2017-04-20 WO disclosed
WO-2016198784-A1 THERMOCHROMIC MAKEUP OR TATTOOING MICROCAPSULES AND COMPOSITION INK AND OUT SAS (FR) 2016-12-15 WO disclosed
US-8859626-B2 Anti-virulence compositions and methods CASE WESTERN RESERVE UNIVERSITY (US) 2014-10-14 US disclosed
US-8616797-B2 Thermosensitive decolorable ink composition MITSUBISHI PENCIL COMPANY, LTD. (JP) 2013-12-31 US disclosed
EP-2412762-A1 THERMOSENSITIVE DECOLORABLE INK COMPOSITION Mitsubishi Pencil Company, Limited (JP) 2012-02-01 EP disclosed
US-20120014740-A1 THERMOSENSITIVE DECOLORABLE INK COMPOSITION MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2012-01-19 US disclosed
US-20110218226-A1 ANTI-VIRULENCE COMPOSITIONS AND METHODS CASE WESTERN RESERVE UNIVERSITY 2011-09-08 US disclosed
WO-2011040680-A2 DYE-SENSITIZED/LIGAND-TO-METAL CHARGE-TRANSFER HYBRID SOLAR CELL COMPRISING A WORKING ELECTRODE INCLUDING NANO-OXIDE LAYER COMPOSED OF NANO-OXIDE PARTICLES ADSORBED WITH DYES AND LIGANDS AND METHOD OF MANUFACTURING THE SAME KOREA INSTITUTE OF ENERGY RESEARCH (KR) 2011-04-07 WO disclosed
EP-1119551-B1 NAPHTHALENECARBOXAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2004-12-29 EP disclosed
EP-1433783-A2 Naphthalenecarboxamides as tachykinin receptor antagonists AstraZeneca AB (SE) 2004-06-30 EP disclosed
EP-1119551-A1 NAPHTHALENECARBOXAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-08-01 EP disclosed
WO-2000020389-A1 NAPHTHALENECARBOXAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE SP1, GPER1, GRIN1 CYP1A2 2409/4885KDM4E 2903/4885MEN1 4073/4885
US-20110218226-A1 ANTI-VIRULENCE COMPOSITIONS AND METHODS ANTXR2, PURB, CAPG CYP1A2 4615/4885KDM4E 2939/4885MEN1 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.